查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439336

深部脑部刺激器 - 全球市场考量、竞争格局、市场预测 (2030)

Deep Brain Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2023年全球深部脑部刺激（DBS）市场规模将达13.1亿美元，2030年将达到23.7亿美元，预计2024-2030年期间复合年增长率为10.40%。由于帕金森氏症等运动障碍的盛行率不断增加、DBS治疗适用的疾病范围扩大、人口老化的增加以及产品开发中研发活动的增加，预计对深部脑刺激设备的需求将不断增长。导致预测期内的市场成长。

深部脑部刺激器的市场动态

由于帕金森氏症、肌张力失调和震颤等各种运动障碍的盛行率不断上升，DBS 设备市场的市场收入正在增加。根据国际帕金森与运动障碍协会International Parkinson and Movement Disorder Society提供的数据，预计2020年全球约有940万人受到帕金森氏症的影响。帕金森氏症与多种临床症状有关，从震颤和姿势不稳定到运动僵硬和缺乏平衡。据报导，深部脑部刺激在治疗帕金森氏症方面具有有益效果，DBS 设备有针对性地刺激神经细胞，有助于缓解症状。因此，帕金森氏症患者数量的增加将增加对DBS设备的需求，预计这将导致深部脑部刺激器市场在预测期内（2024-2030年）出现正成长。

导致 DBS 设备需求增加的另一个主要因素是全球癫痫患者数量的增加。根据世界卫生组织（WHO）提供的数据，2019年全球有近5,000万人患有癫痫症，使其成为世界上最常见的神经系统疾病之一。癫痫的特征是不同长度的反覆发作。据报导，深部脑部刺激对于对药物治疗无反应且不适合癫痫手术的癫痫患者有益。因此，癫痫族群的增加预计也将带动对DBS设备的需求，进而带动深部脑部刺激器市场的成长。

除了上述参数外，老年人口的增加、DBS设备治疗适应症的扩大、高度活跃的脑深部刺激产品研发等也将在预测期内积极刺激脑深部刺激系统市场，这是主要因素。

然而，与DBS设备安装手术相关的併发症以及市场上最终用户对DBS系统的选择有限可能是DBS设备市场成长的某些限制因素。

除了上述因素之外，由于作为遏制 COVID-19 传播的必要措施而实施的封锁，深部脑部刺激市场经历了暂时的挫折。这段期间的主要措施之一是暂停了许多择期手术和门诊，这减少了市场对 DBS 设备的需求，并在短时间内限制了市场成长。然而，随着世界各地多种 COVID-19 疫苗的批准和管理，深部脑部刺激器市场正处于恢復阶段，导致包括医疗保健服务在内的各个领域的活动恢復。

深部脑部刺激器市场区隔分析

在深部脑部刺激设备市场的产品类型部分，预计双通道深部脑部刺激系统在预测期内将占据显着的市场份额。这可以归因于双通道神经刺激器具有两个独立的 DBS 引线，从而对患者进行双边治疗。事实证明，双通道 DBS 系统的放置比单通道 DBS 系统更具优势，因为它们需要更少的切口和更少的延伸隧道。因此，预计上述因素将对预测期内双通道 DBS 设备的需求产生正面影响，并有助于预测期内深部脑部刺激设备市场的整体成长。

预计北美将主导整个深部脑部刺激器市场。

在所有地区中，北美预计将占据 DBS 设备市场的主要市场份额。由于运动障碍和强迫症(OCD) 等适应症的高盛行率、人们对这些疾病和可能的治疗方法的认识不断提高，以及人口老龄化不断增加，政府加大了提高认识的努力，预计北美将占据主导市场份额有关运动障碍和治疗等的研究，预计将推动北美深部脑部刺激器市场的成长。此外，高可支配收入、先进的医疗基础设施、新产品批准和持续的产品开发也推动了该地区的市场成长。

本报告研究分析了全球深部脑部刺激器市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第一章深部脑部刺激器市场报告简介

第二章深部脑部刺激器市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估
  • 财务基准

第三章 法规与专利分析

  • 美国
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
  • 日本

第四章深部脑部刺激器市场关键因素分析

  • 深部脑部刺激器市场驱动因素
    • 运动障碍盛行率上升
    • 扩大 DBS 疗法适用的疾病范围
    • 老年人口增加
    • 改进 DBS 设备的产品设计与功能
  • 深部脑部刺激器市场的抑制因素与挑战
    • DBS 手术相关的併发症
    • 最终用户的 DBS 系统选择有限
  • 深部脑部刺激器市场机会
    • 推出针对新兴市场的产品
    • 提高产品安全性

第五章 波特五力分析深部脑部刺激器市场

第六章 COVID-19对深部脑部刺激器市场的影响分析

第七章 深部脑部刺激器市场布局

  • 按产品类型
    • 单通道DBS设备
    • 双通道DBS设备
  • 依电池类型
    • 可充电的
    • 不可充电
  • 按用途
    • 帕金森病
    • 癫痫
    • 强迫症
    • 肌张力失调
    • 其他
  • 按最终用户
    • 医院
    • 专科诊所
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第八章脑深部刺激设备市场：全球公司份额分析- 3至5家主要公司

第九章深部脑部刺激器市场公司与产品概况

  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • ALEVA NEUROTHERAPEUTICS SA.
  • Beijing PINS Medical Co., Ltd.
  • Newronika S.p.A.

第10章 项目方法

  • 二次资料
  • 一次资料
  • 数据三角测量
  • 主要专家意见

第11章 KOL观点

第12章 DelveInsight服务内容

第13章 免责声明

第 14 章关于 DelveInsight

Product Code: DIMDCL0128

Deep Brain Stimulation Devices Market By Product Type (Single Channel And Dual Channel), By Battery Type (Rechargeable And Non-Rechargeable), By Application (Parkinson's Disease, Epilepsy, Obsessive Compulsive Disorder, Dystonia, And Others), By End User (Hospitals And Specialty Clinics), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of parkinson's disease and epilepsy.

Global Deep Brain Stimulation Devices (DBS) Market was valued at USD 1.31 billion in 2023, growing at a CAGR of 10.40% during the forecast period from 2024 to 2030 to reach USD 2.37 billion by 2030. The demand for deep brain stimulation devices is witnessing growth owing to the growing prevalence of movement disorders such as Parkinson's disease, expansion of disease indications for DBS therapy, rising geriatric population, and increasing research and development activities in product development are expected to aid in the growing demand for DBS devices leading to the growth of the DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Dynamics:

The DBS devices market is witnessing an increase in market revenue owing to the rising prevalence of various movement disorders such as Parkinson's disease, dystonia and tremors among others. According to the data provided by the International Parkinson and Movement Disorder Society, it was estimated that in 2020, approximately 9.4 million of the global population was suffering from Parkinson's disease. Parkinson's disease is associated with a variety of clinical manifestations ranging from tremors and postural instability to rigidity in movement and lack of balance. Deep brain stimulation has been reported to provide beneficial outcomes in the treatment of Parkinson's disease, wherein targeted stimulation of neurons by DBS devices help in the alleviation of symptoms. Therefore, the demand for DBS devices is set to increase due to the rising number of Parkinson's disease patients, thereby projecting positive growth for the deep brain stimulation devices market during the forecast period (2024-2030).

Another key factor leading to the increased demand for the DBS devices is the increase in the prevalent population of epilepsy patients across the globe. As per the data provided by the World Health Organization, in 2019, near about 50 million people across the world had epilepsy making it one of the most common neurological diseases in the world. Epilepsy is characterized by recurrent seizures of varying lengths. Deep brain stimulation has been reported to be beneficial for epilepsy patients who have not been benefitted from medications and do not qualify for epilepsy surgery. Therefore, the rising epileptic population is also expected to drive the demand for DBS devices, which in turn would result in the growth of the deep brain stimulation devices market.

Along with the aforementioned parameters, the rising geriatric population, expansion of indications to be treated with DBS devices and the highly active research and development area for the deep brain stimulation products are some of the other key contributing factors which will stimulate the deep brain stimulation systems market positively during the forecast period.

However, complications associated with the DBS devices placement surgery, limited options of DBS systems for end users in the market may prove to be certain restraints to the DBS devices market growth.

In addition to the previously mentioned factors, the deep brain stimulation market witnessed a period of temporary setback due to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for DBS devices in the market, thereby limiting the market growth for a short time. Nevertheless, the market for deep brain stimulation devices is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Segment Analysis:

Deep Brain Stimulation Devices Market by Product Type (Single Channel and Dual Channel), by Battery Type (Rechargeable and Non-Rechargeable), by Application (Parkinson's Disease, Epilepsy, Obsessive Compulsive Disorder, Dystonia, and Others), by End User (Hospitals and Specialty Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the deep brain stimulation devices market, the dual channel deep brain stimulation systems are estimated to account for the prominent market share during the forecast period. This can be ascribed to the fact that dual channel neurostimulators are equipped with two separate DBS leads which enable the devices to provide bilateral therapy to patients. The placement of dual channel DBS systems require fewer incisions and less tunneling of extensions which prove to be advantageous over single-channel DBS systems. Thus, the factors mentioned above are going to influence the demand for dual channel DBS devices positively during the forecast period, thereby contributing in the overall growth of the deep brain stimulation devices market during the forecast period.

North Amercia is expected to dominate the overall Deep Brain Stimulation Devices Market:

Among all the regions, North America is expected to account for the significant market share in the DBS devices market. North America is predicted to account for the dominant market share because of the high prevalence of movement disorders and other indications such as obsessive compulsive disorder (OCD), increasing awareness regarding such diseases and their possible treatment methods, rising population of the elderly as well as rising government initiatives for creating awareness regarding movement disorders and treatment are expected to aid in the growth of the North America deep brain stimulation devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and advancements in product development also propelled the market growth in this region.

The North American DBS devices market is witnessing an upward trend due to the rising prevalence of obsessive compulsive disorder among other factors. As per the data provided by the Anxiety & Depression Association of America, in 2020, near about 2.2 million people were diagnosed with OCD in the United States. It has been reported in many studies that deep brain stimulation has proven to be beneficial in alleviating OCD symptoms in patients. Therefore, the increase in patient population of OCD in the United States is expected to aid in the growing demand for DBS devices, which in turn in expected to drive the growth of the United States deep brain stimulation devices market.

Besides United States, the demand for DBS devices is set to increase in other North American countries such as Canada also due to the increase in patient population of movement disorders such as Parkinson's disease. According to the data provided by a Canada-based organization-Parkinson Canada, in 2020, approximately 100,000 people were living were PD in the country. The data further stated that from the current average of 25 Canadians being diagnosed with Parkinson's disease each day, the average is expected to rise to 50 people per day by 2031. Therefore, the estimates regarding the increase in patient population of PD in Canada would lead to the increase in demand for deep brain stimulation devices, thereby providing a positive market outlook for the DBS systems market during the forecast period.

Along with the factors mentioned above, the conducive environment for product development and launches in the country further motivates the market players to enhance their presence in North America. For instance, in 2018, the US Food and Drug Administration approved DBS therapy for epilepsy thereby expanding the scope of indications, which in turn is expected to contribute to the increase in product demand thereby supporting the growth of the North America DBS devices market during the forecast period.

Deep Brain Stimulation Devices Market Key Players:

Some of the key market players operating in the DBS devices market includes Abbott, Medtronic, Boston Scientific Corporation, ALEVA NEUROTHERAPEUTICS SA., Newronika S.p.A., Beijing PINS Medical Co., Ltd. and others.

Recent Developmental Activities in Deep Brain Stimulation Devices Market:

In June 2022, Medtronic received the product approval by the US Food and Drug Administration for First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy.

In January 2022, Boston Scientific received the product approval from the US FDA for their fourth generation Vercise Genus Deep Brain Stimulation (DBS) System used in the treatment of symptoms associated with advanced Parkinson's disease.

In September 2020, Boston Scientific received the CE mark approval from the Vercise Genus Deep Brain Stimulation (DBS) System used in the treatment of symptoms associated with advanced Parkinson's disease.

Key Takeaways from the Deep Brain Stimulation Devices Market Report Study

Market size analysis for current DBS devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the DBS devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global DBS devices market.

Various opportunities available for the other competitor in the DBS devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current DBS devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for DBS devices market growth in the coming future?

Target Audience who can be benefited from this Deep Brain Stimulation Devices Market Report Study

Deep Brain Stimulation Devices products providers

Research organizations and consulting companies

Deep Brain Stimulation Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in DBS devices

Various End-users who want to know more about the DBS devices market and latest technological developments in the DBS devices market.

Frequently Asked Questions for Deep Brain Stimulation Devices Market:

1. What is a Deep Brain Stimulation Device?

Deep brain stimulation (DBS) is a device that sends electrical signals to brain areas responsible for body movement. Electrodes are placed deep in the brain and are connected to a stimulator device. The device design in identical to that of a heart pacemaker.

2. What is the market for Global Deep Brain Stimulation Devices?

Global Deep Brain Stimulation Devices (DBS) Market was valued at USD 1.31 billion in 2023, growing at a CAGR of 10.40% during the forecast period from 2024 to 2030 to reach USD 2.37 billion by 2030.

3. What are the drivers for Global Deep Brain Stimulation Devices Market?

The demand for deep brain stimulation devices is witnessing growth due to the growing prevalence of movement disorders such as Parkinson's disease, expansion of disease indications for DBS therapy, rising geriatric population, and increasing research and development activities in product development are expected to aid in the growing demand for DBS devices leading to the growth of the DBS devices market in the forecast period.

4. Who are the key players operating in Global Deep Brain Stimulation Devices Market?

Some of the key market players operating in the Global DBS systems market are Abbott, Medtronic, Boston Scientific Corporation, ALEVA NEUROTHERAPEUTICS SA., Newronika S.p.A., Beijing PINS Medical Co., Ltd. and others.

5. Which region has the highest share in Deep Brain Stimulation Devices market?

Among all the regions, North America is expected to account for the significant market share in the DBS devices market. North America is predicted to account for the dominant market share because of the high prevalence of movement disorders and other indications such as obsessive compulsive disorder (OCD), increasing awareness regarding such diseases and their possible treatment methods, rising population of the elderly as well as rising government initiatives for creating awareness regarding movement disorders and treatment are expected to aid in the growth of the North America deep brain stimulation devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and advancements in product development also propelled the market growth in this region.

Table of Contents

1. Deep Brain Stimulation Devices Market Report Introduction

2. Deep Brain Stimulation Devices Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
    • 3.2.1 Germany
    • 3.2.2 France
    • 3.2.3 Italy
    • 3.2.4 Spain
    • 3.2.5 U.K.
  • 3.3 Japan

4. Deep Brain Stimulation Devices Market Key Factors Analysis

  • 4.1 Deep Brain Stimulation Devices Market Drivers
    • 4.1.1 Rising Prevalence of Movement Disorders
    • 4.1.2 Expansion of Disease Indications for DBS Therapy
    • 4.1.3 Rising Geriatric Population
    • 4.1.4 Improving Product Design and Features of DBS Devices
  • 4.2 Deep Brain Stimulation Devices Market Restraints and Challenges
    • 4.2.1 Complications Associated with DBS Procedures
    • 4.2.2 Limited Options of DBS Systems for End Users
  • 4.3 Deep Brain Stimulation Devices Market Opportunities
    • 4.3.1 Targeting Emerging Markets for Product Launches
    • 4.3.2 Product Improvement in Terms of Safety

5. Deep Brain Stimulation Devices Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Deep Brain Stimulation Devices Market

7. Deep Brain Stimulation Devices Market Layout

  • 7.1 By Product Type
    • 7.1.1 Single-Channel DBS Devices
    • 7.1.2 Dual-Channel DBS Devices
  • 7.2 By Battery Type
    • 7.2.1 Rechargeable
    • 7.2.2 Non-rechargeable
  • 7.3 By Application
    • 7.3.1 Parkinson's Disease
    • 7.3.2 Epilepsy
    • 7.3.3 Obsessive Compulsive Disorder
    • 7.3.4 Dystonia
    • 7.3.5 Others
  • 7.4 By End User
    • 7.4.1 Hospitals
    • 7.4.2 Specialty Clinics
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 North America Deep Brain Stimulation Devices Market, by Product Type
      • 7.5.1.2 North America Deep Brain Stimulation Devices Market, by Battery Type
      • 7.5.1.3 North America Deep Brain Stimulation Devices Market, by Application
      • 7.5.1.4 North America Deep Brain Stimulation Devices Market, by End User
      • 7.5.1.5 North America Deep Brain Stimulation Devices Market, by Country
      • 7.5.1.5.1 United States
      • 7.5.1.5.2 Canada
      • 7.5.1.5.3 Mexico
    • 7.5.2 Europe
      • 7.5.2.1 Europe Deep Brain Stimulation Devices Market, by Product Type
      • 7.5.2.2 Europe Deep Brain Stimulation Devices Market, by Battery Type
      • 7.5.2.3 Europe Deep Brain Stimulation Devices Market, by Application
      • 7.5.2.4 Europe Deep Brain Stimulation Devices Market, by End User
      • 7.5.2.5 Europe Deep Brain Stimulation Devices Market, by Country
      • 7.5.2.5.1 France
      • 7.5.2.5.2 Germany
      • 7.5.2.5.3 United Kingdom
      • 7.5.2.5.4 Italy
      • 7.5.2.5.5 Spain
      • 7.5.2.5.6 Russia
      • 7.5.2.5.7 Rest of Europe
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 Asia-Pacific Deep Brain Stimulation Devices Market, by Product Type
      • 7.5.3.2 Asia-Pacific Deep Brain Stimulation Devices Market, by Battery Type
      • 7.5.3.3 Asia-Pacific Deep Brain Stimulation Devices Market, by Application
      • 7.5.3.4 Asia-Pacific Deep Brain Stimulation Devices Market, by End User
      • 7.5.3.5 Asia-Pacific Deep Brain Stimulation Devices Market, by Country
      • 7.5.3.5.1 China
      • 7.5.3.5.2 Japan
      • 7.5.3.5.3 India
      • 7.5.3.5.4 Australia
      • 7.5.3.5.5 South Korea
      • 7.5.3.5.6 Rest of Asia Pacific
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 RoW Deep Brain Stimulation Devices Market, by Product Type
      • 7.5.4.2 RoW Deep Brain Stimulation Devices Market, by Battery Type
      • 7.5.4.3 RoW Deep Brain Stimulation Devices Market, by Application
      • 7.5.4.4 RoW Deep Brain Stimulation Devices Market, by End User
      • 7.5.4.5 RoW Deep Brain Stimulation Devices Market, by Country
      • 7.5.4.5.1 Middle East
      • 7.5.4.5.2 Africa
      • 7.5.4.5.3 South America

8. Deep Brain Stimulation Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Deep Brain Stimulation Devices Market Company and Product Profiles

  • 9.1 Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Medtronic
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Boston Scientific Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 ALEVA NEUROTHERAPEUTICS SA.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Beijing PINS Medical Co., Ltd.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Newronika S.p.A.,
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy

10. PROJECT APPROACH

  • 10.1 Secondary Sources
  • 10.2 Primary Sources
  • 10.3 Data Triangulation
  • 10.4 Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis
  • Table 3 Dep Brain Stimulation Devices in Global (2021-2030)
  • Table 4 Deep Brain Stimulation Devices in Global by Product Type (2021-2030)
  • Table 5 Deep Brain Stimulation Devices in Global by Battery Type (2021-2030)
  • Table 6 Deep Brain Stimulation Devices in Global by Application (2021-2030)
  • Table 7 Deep Brain Stimulation Devices in Global by End User (2021-2030)
  • Table 8 Deep Brain Stimulation Devices in Global by Geography (2021-2030)
  • Table 9 Deep Brain Stimulation Devices in North America (2021-2030)
  • Table 10 Deep Brain Stimulation Devices in North America by Product Type (2021-2030)
  • Table 11 Deep Brain Stimulation Devices in North America by Battery Type (2021-2030)
  • Table 12 Deep Brain Stimulation Devices in North America by Application (2021-2030)
  • Table 13 Deep Brain Stimulation Devices in North America by End User (2021-2030)
  • Table 14 Deep Brain Stimulation Devices in North America by Country (2021-2030)
  • Table 15 Deep Brain Stimulation Devices in the US (2021-2030)
  • Table 16 Deep Brain Stimulation Devices in Canada (2021-2030)
  • Table 17 Deep Brain Stimulation Devices in Mexico (2021-2030)
  • Table 18 Deep Brain Stimulation Devices in Europe (2021-2030)
  • Table 19 Deep Brain Stimulation Devices in Europe by Product Type (2021-2030)
  • Table 20 Deep Brain Stimulation Devices in Europe by Battery Type (2021-2030)
  • Table 21 Deep Brain Stimulation Devices in Europe by Application (2021-2030)
  • Table 22 Deep Brain Stimulation Devices in Europe by End User (2021-2030)
  • Table 23 Deep Brain Stimulation Devices in Europe by Country (2021-2030)
  • Table 24 Deep Brain Stimulation Devices in France (2021-2030)
  • Table 25 Deep Brain Stimulation Devices in Germany (2021-2030)
  • Table 26 Deep Brain Stimulation Devices in the United Kingdom (2021-2030)
  • Table 27 Deep Brain Stimulation Devices in Italy (2021-2030)
  • Table 28 Deep Brain Stimulation Devices in Spain (2021-2030)
  • Table 29 Deep Brain Stimulation Devices in Russia (2021-2030)
  • Table 30 Deep Brain Stimulation Devices in Rest of Europe (2021-2030)
  • Table 31 Deep Brain Stimulation Devices in APAC (2021-2030)
  • Table 32 Deep Brain Stimulation Devices in APAC by Product Type (2021-2030)
  • Table 33 Deep Brain Stimulation Devices in APAC by Battery Type (2021-2030)
  • Table 34 Deep Brain Stimulation Devices in APAC by Application (2021-2030)
  • Table 35 Deep Brain Stimulation Devices in APAC by End User (2021-2030)
  • Table 36 Deep Brain Stimulation Devices in APAC by Country (2021-2030)
  • Table 37 Deep Brain Stimulation Devices in China (2021-2030)
  • Table 38 Deep Brain Stimulation Devices in Japan (2021-2030)
  • Table 39 Deep Brain Stimulation Devices in India (2021-2030)
  • Table 40 Deep Brain Stimulation Devices in Australia (2021-2030)
  • Table 41 Deep Brain Stimulation Devices in South Korea (2021-2030)
  • Table 42 Deep Brain Stimulation Devices in Rest of APAC (2021-2030)
  • Table 43 Deep Brain Stimulation Devices in Rest of World (2021-2030)
  • Table 44 Deep Brain Stimulation Devices in RoW by Product Type (2021-2030)
  • Table 45 Deep Brain Stimulation Devices in RoW by Battery Type (2021-2030)
  • Table 46 Deep Brain Stimulation Devices in RoW by Application (2021-2030)
  • Table 47 Deep Brain Stimulation Devices in RoW by End User (2021-2030)
  • Table 48 Deep Brain Stimulation Devices in RoW by Region (2021-2030)
  • Table 49 Deep Brain Stimulation Devices in Middle East (2021-2030)
  • Table 50 Deep Brain Stimulation Devices in Africa (2021-2030)
  • Table 51 Deep Brain Stimulation Devices in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis
  • Figure 3 Deep Brain Stimulation Devices in Global (2021-2030)
  • Figure 4 Deep Brain Stimulation Devices in Global by Product Type (2021-2030)
  • Figure 5 Deep Brain Stimulation Devices in Global by Battery Type (2021-2030)
  • Figure 6 Deep Brain Stimulation Devices in Global by Application (2021-2030)
  • Figure 7 Deep Brain Stimulation Devices in Global by End User (2021-2030)
  • Figure 8 Deep Brain Stimulation Devices in Global by Geography (2021-2030)
  • Figure 9 Deep Brain Stimulation Devices in North America (2021-2030)
  • Figure 10 Deep Brain Stimulation Devices in North America by Product Type (2021-2030)
  • Figure 11 Deep Brain Stimulation Devices in North America by Battery Type (2021-2030)
  • Figure 12 Deep Brain Stimulation Devices in North America by Application (2021-2030)
  • Figure 13 Deep Brain Stimulation Devices in North America by End User (2021-2030)
  • Figure 14 Deep Brain Stimulation Devices in North America by Country (2021-2030)
  • Figure 15 Deep Brain Stimulation Devices in the US (2021-2030)
  • Figure 16 Deep Brain Stimulation Devices in Canada (2021-2030)
  • Figure 17 Deep Brain Stimulation Devices in Mexico (2021-2030)
  • Figure 18 Deep Brain Stimulation Devices in Europe (2021-2030)
  • Figure 19 Deep Brain Stimulation Devices in Europe by Product Type (2021-2030)
  • Figure 20 Deep Brain Stimulation Devices in Europe by Battery Type (2021-2030)
  • Figure 21 Deep Brain Stimulation Devices in Europe by Application (2021-2030)
  • Figure 22 Deep Brain Stimulation Devices in Europe by End User (2021-2030)
  • Figure 23 Deep Brain Stimulation Devices in Europe by Country (2021-2030)
  • Figure 24 Deep Brain Stimulation Devices in France (2021-2030)
  • Figure 25 Deep Brain Stimulation Devices in Germany (2021-2030)
  • Figure 26 Deep Brain Stimulation Devices in the United Kingdom (2021-2030)
  • Figure 27 Deep Brain Stimulation Devices in Italy (2021-2030)
  • Figure 28 Deep Brain Stimulation Devices in Spain (2021-2030)
  • Figure 29 Deep Brain Stimulation Devices in Russia (2021-2030)
  • Figure 30 Deep Brain Stimulation Devices in Rest of Europe (2021-2030)
  • Figure 31 Deep Brain Stimulation Devices in APAC (2021-2030)
  • Figure 32 Deep Brain Stimulation Devices in APAC by Product Type (2021-2030)
  • Figure 33 Deep Brain Stimulation Devices in APAC by Battery Type (2021-2030)
  • Figure 34 Deep Brain Stimulation Devices in APAC by Application (2021-2030)
  • Figure 35 Deep Brain Stimulation Devices in APAC by End User (2021-2030)
  • Figure 36 Deep Brain Stimulation Devices in APAC by Country (2021-2030)
  • Figure 37 Deep Brain Stimulation Devices in China (2021-2030)
  • Figure 38 Deep Brain Stimulation Devices in Japan (2021-2030)
  • Figure 39 Deep Brain Stimulation Devices in India (2021-2030)
  • Figure 40 Deep Brain Stimulation Devices in Australia (2021-2030)
  • Figure 41 Deep Brain Stimulation Devices in South Korea (2021-2030)
  • Figure 42 Deep Brain Stimulation Devices in Rest of APAC (2021-2030)
  • Figure 43 Deep Brain Stimulation Devices in Rest of World (2021-2030)
  • Figure 44 Deep Brain Stimulation Devices in RoW by Product Type (2021-2030)
  • Figure 45 Deep Brain Stimulation Devices in RoW by Battery Type (2021-2030)
  • Figure 46 Deep Brain Stimulation Devices in RoW by Application (2021-2030)
  • Figure 47 Deep Brain Stimulation Devices in RoW by End User (2021-2030)
  • Figure 48 Deep Brain Stimulation Devices in RoW by Region (2021-2030)
  • Figure 49 Deep Brain Stimulation Devices in Middle East (2021-2030)
  • Figure 50 Deep Brain Stimulation Devices in Africa (2021-2030)
  • Figure 51 Deep Brain Stimulation Devices in South America (2021-2030)
  • Figure 52 Market Drivers
  • Figure 53 Market Barriers
  • Figure 54 Marker Opportunities
  • Figure 55 PORTER'S Five Force Analysis